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ABSTRACT 
The role of collagen specific α2β1 integrin in anchorage dependent apoptosis (anoikis) was 
investigated. Stimulation of α2β1 signaling with immobilized anti-α2 antibody markedly 
sensitized human MCF-7 breast carcinoma and HepG2 hepatoma cells to anoikis. 
Accordingly, down-regulation of α2β1 by α2-specific siRNA decreased the percentage of 
cells undergoing anoikis. These results for the first time provide direct evidence that α2β1 
receptor can transduce the signal to promote death in matrix deprived cells.  
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INTRODUCTION 
Altered response of tumor cells to 
environmental stimuli is a pleiotropic 
phenomenon. Integrins, the receptors that 
mediate interactions of cells with 
extracellular matrix, are intensely 
investigated as key regulators of cell 
survival. The function of integrins in 
maintaining cell viability is substantiated by 
their role in anchorage dependent apoptosis 
(anoikis)  (Frisch and Screaton  2001; 
Cheresh and Stupack  2002). This type of 
apoptosis is triggered by cell detachment 
from matrix (Frisch and Screaton 2001; 
Frisch and Ruoslahti 1997). 
 
Integrin mediated signaling pathways that 
regulate cell survival remain poorly 
understood. Integrins are commonly thought 
to transduce pro-survival signals when cells 
interact with matrix. Upon disruption of cell-
matrix contacts integrins trigger death 
signaling (Frisch and Screaton 2001; Frisch 
and Ruoslahti 1994). However, in a limited 
number of studies integrins have been shown 
to promote cell death (Cheresh and Stupack  
2002; Kozlova et.al. 2001; Marco RA et.al 
2003). We have shown that vitronectin 
specific integrin αvβ3 promoted anoikis of 
colon carcinoma cells (Kozlova  et.al. 2001) 
Moreover, in our experiments the loss of 
α2β1 collagen specific integrin was 
associated with higher resistance to anoikis 
in breast carcinoma cells selected for 
multidrug resistance (Morozevich et.al. 
2006). 
 
Based on these results we set out to explore 
the role of α2β1 receptor in regulation of cell 
death. The α2β1 signaling was stimulated by 
the cross-linking antibody; alternatively, the 
function of α2β1 was attenuated by genetic 
down-regulation of α2 subunit. We report 
that stimulation of α2β1 signaling in two cell 
lines of different tisssue origin, namely, 
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breast carcinoma MCF-7 and hepatoma 
HepG2, promotes anoikis whereas down-
regulation of this receptor attenuates anoikis. 
These results for the first time provide the 
direct evidence for stimulation of anoikis via 
α2β1 receptor. 
 
MATERIALS AND METHODS 
 
Cells and reagents 
The MCF-7 breast carcinoma and HepG2 
hepatoma cell lines (obtained from American 
Type Culture Collection, Manassas, VA) 
were cultured in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS; Hyclone), 2 mM L-
glutamine, 100 U/ml penicillin and 100 
μg/ml streptomycin at 370C, 5%CO2 in 
humidified atmosphere. The reagents were 
from Sigma Chemical Co., St.Louis, MO 
unless specified otherwise. Anti-human α2β1 
monoclonal antibody (mAb) BHA2.1 and 
rabbit polyclonal antibodies to human α2 
subunit were purchased from Chemicon 
(Temecula, CA). ICO-53 mAb to human 
HLA-ABC histocompatibility complex was a 
gift of A.Baryshnikov (N.N.Blokhin Cancer 
Center, Moscow). The mAb against α-
tubulin and siRNA duplexes specific to α2 
subunit and control siRNA were from Santa 
Cruz Biotech. (Santa Cruz, CA). Reagents 
for reverse transcription and polymerase 
chain reaction (RT-PCR) were from 
Invitrogen (Carlsbad, CA). 
 
siRNA Transfection 
The procedure was performed according to 
the manufacturer’s instructions (Santa Cruz 
Biotech.). Briefly, 1-2x105 cells in 1 ml of 
antibiotic-free DMEM + 10% FBS were 
plated into each well of 12-well culture plates 
(Corning, Big Flats, NY). After reaching 
~50% confluence the cells were transfected 
with 50 nM siRNA (final concentration) for 
48 h using siRNA transfection reagent. Then 
cells were harvested with trypsin/EDTA, 
washed three times with antibiotic-free 
DMEM+10% FBS, plated on 12-well plates 
and incubated in the same medium 
containing 1 μCi [U-14C]thymidine 
(Amersham, UK). When the cells reached 
~50% confluence, they were repeatedly 
transfected with respective siRNAs for 
another 48 h using the same conditions. 
 
Cell Stimulation with Immobilized Antibody 
Twenty four well plates (Corning) were 
coated with 25 μg/ml  rabbit anti-mouse 
polyclonal antibodies (Sigma) in phosphate 
buffered saline (PBS) for 2 h at 370 C 
followed by blocking with bovine serum 
albumin (BSA; 10 mg/ml in PBS) at 370C for 
1 h. The plates were then coated with 1:100 
dilutions of control or anti-α2 mAb for 18 h 
at 40C. The separate plates were coated with 
200 μg/ml poly-L-lysine (PLL, MP-
Biomedicals, Germany) at 40C for 18 h.  
Then plates were washed three times with 
medium and used for cell plating. Cells at log 
phase were incubated in complete growth 
medium contaning [U-14C]thymidine (4 
μCi/106 cells) for 18 h at 370C, washed and 
harvested in the medium containing 2.5% 
FBS. Labeled cells were plated on 
immobilized anti-integrin antibodies or PLL 
and incubated at 370C for 24 h. Then cells 
were collected and subjected to anoikis. 
 
Induction and Quantitation of Anoikis. 
The non-adhesive substrate polyhydroxyethyl 
metacrylate (poly-HEМA, Sigma) was 
prepared in 48-well plates as described 
(McGahon et.al. 1995). Cells treated with 
siRNA or immobilized antibody and labeled 
with [U-14C]thymidine were plated on poly-
HEMA–coated wells and incubated at 370C 
for 24 h. Anoikis was quantitated as in refs. 
[McGahon et.al. 1995; A Patki and 
Lederman 1996; Kozlova et.al. 2001]. 
 
RT-PCR 
Isolation of total cellular RNA, RT and PCR 
were performed as described (Kozlova et.al. 
2001). The following primers were used to 
amplify the fragments of human α2 (541 bp) 
and β-actin (540 bp) cDNAs: α2: 5’-
TGGGGTGCAAACAGACAAGG-3’ 
(forward), 5’-GTAGGTCTGCTGGTTCAG-
3’ (reverse); β-actin (internal standard): 5’-
GTGGGGCGCCCCAGGCACCA-3’ 
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(forward), 5’-
CTCCTTAATGTCACGCACGATTTC-3’ 
(reverse). In preliminary experiments the 
reaction conditions were established to find 
the optimal number of cycles within the 
exponential range of the yield of PCR 
products. The PCR products were resolved in 
1.5 % agarose gel, scanned and analyzed 
using ImageJ NIH software. 
 
Western Blotting 
The procedure was performed as described in 
ref. (Kozlova et.al. 1997). Blots were 
incubated with primary antibodies at 
indicated dilutions (see Figure Legends) for 1 
h at room temperature followed by addition 
of horseradish peroxidase (HRP)-conjugated 
secondary antibodies (1:5000, 1 h at room 
temperature). Proteins were detected using 
Enhanced Chemoluminescence System 
(Amersham). Scanning densitometry with 
ImageJ NIH software was used to calculate 
relative expression of proteins. 
 
Statistical Analysis was carried out using 
Student’s t-test. Differences between groups 
with p<0.05 were considered statistically 
significant. 
 
RESULTS AND DISCUSSION 
Stimulation of α2β1 Signaling Potentiates 
Anoikis of MCF-7 and HepG2 Cells 
The idea to implicate α2β1 integrin in 
promotion of anoikis stemmed from our 
observation that this receptor was 
dramatically down-regulated in multidrug 
resistant MCF-7Dox cells compared with 
their parental MCF-7 counterparts 
(Morozevich  et.al. 2006). The loss of α2β1 
receptor correlated with markedly decreased 
anoikis in MCF-7Dox cells. These data 
allowed us to hypothesize that in wild type 
MCF-7 cells α2β1 integrin might mediate 
death signaling after the cells lose contact 
with matrix, and stimulation of this integrin 
is expected to be pro-apoptotic. Likewise, 
down-regulation of α2β1 would rescue cells 
from anoikis. 
 
To test this hypothesis, MCF-7 cells were 
attached to anti-integrin antibodies 
immobilized on the solid support. Adhesion 
to immobilized antibodies is known to cause 
clustering of surface receptors and trigger 
signaling via these receptors ( Kozlova  et.al. 
2001; Stromblad et.al. 1996). We have 
previosly found that treatment with anti-β1 
antibody promoted anoikis of MCF-7 cells 
(1.7-fold increase of anoikis compared to 
cells exposed to anti-HLA antibody or PLL 
(Morozevich  et.al.  2006). Among the β1 
family integrins expressed in MCF-7 cells, 
the α2β1 receptor was found on the surface 
of 90% cells (Table 1). As shown in Fig. 1, in 
MCF-7 cells incubated on immobilized anti-
α2β1 antibody, anoikis was markedly 
enhanced (up to 1.8-fold increase compared 
to cells treated with anti-HLA antibody or 
PLL). These data implicate the α2β1 
receptor in transducing the signal(s) to 
promote the substrate dependent cell death.  
 
We next sought to expand our observations 
to an independent model with similar 
spectrum of β1 family integrins. Table 1 
shows that the expression of α2, α3, αv and 
β1 subunits was close in MCF-7 and HepG2 
cell lines. The major β1 integrin expressed 
on HepG2 cells was α2β1 receptor (~70% 
positive cells; Table 1). In agreement with 
the results obtained with MCF-7 cells, 
stimulation of α2β1 signaling in HepG2 cells 
increased the percentage of anoikis up to 1.5-
fold compared with mock-stimulated cells 
(Fig. 1). Of note, matrix deprived MCF-7 and 
HepG2 cells displayed an apoptotic mode of 
death as determined by the ‘laddering’ of 
DNA fragments in agarose gel 
electrophoresis and an increased number of 
cells with sub-diploid DNA content (by flow 
cytometry analysis) (data not shown).  
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Figure 1: Effect of  antibody-induced activation of  α2β1 integrin on anoikis in MCF-7 
and HepG2 cells.  2.5x105 cells labeled with [U-14C]thymidine were resuspended in 
DMEM containing 2.5% FBS,  transferred into 24-well plates coated with ICO-53 anti-
HLA  mAb (control; closed bars), PLL (hatched bars) or  BHA2.1 anti-α2β1 mAb 
(open bars) and incubated at 370C for 24 h. Then cells were harvested in DMEM with 
2.5% FBS and incubated in 48-well plates coated with poly-HEMA at 370C for 24 h. 
After exposure to poly-HEMA, cells were lysed in buffered 0.4% Triton X-100. Intact 
DNA was pelleted (Kozlova et al., 2001; McGahon et al.,1995). Anoikis was 
calculated as ratio c.p.m. supernatant/ c.p.m. supernatant + c.p.m. pellet (McGahon 
et al.,1995). Apoptosis of  ICO-53-treated cells was regarded as 100%. Shown are 
the mean  ± s.e.m. of three independent experiments with four replicates in each. *P 
< 0.02 compared to control. 
 
Table 1: Analysis of Integrin Expression in MCF-7 and HepG2 Cells by Flow Cytometry. 
 
    Integrin           MCF-7                          HepG2   
     subunit                                                   
                                                                 
                                 
   α2                90 ± 1.0                          70 ± 6.0                                
   α3                43 ± 6.0                          32 ± 3.0               
   αv                39 ± 4.0                          50 ± 2.0    
   β1                93 ± 1.0                          86 ± 2.0              
            
Two hundred thousand cells were resuspended in 50 μl of ice-cold PBS, incubated 
with integrin subunit-specific antibodies diluted 1:200 for 1 h at 40C, pelleted and 
washed twice with PBS. Cells were then incubated with fluorescein isothiocyanate 
(FITC)-conjugated rabbit anti-mouse IgG (1:300) for 30 min. at room temperature, 
washed with PBS and fixed with 1% formaldehyde in PBS. Flow cytometry was 
performed on FACS Calibur (Becton Dickinson, San Jose, CA) on FL1. Ten thousand 
events were collected per each sample. Data represent the percent of cells 
expressing the respective integrin subunit (mean ± s.e.m. of four independent 
experiments). 
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Silencing of α2β1 Attenuates Anoikis in 
MCF-7 and HepG2 Cell Lines 
To further substantiate the role of α2β1 
receptor in anoikis we used α2-specific 
siRNA to down-regulate α2 expression. 
Figure 2 shows that transfection of α2-
siRNA markedly decreased the expression of 
α2 mRNA and protein in both MCF-7 and 
HepG2 cell lines. Furthermore, down-
regulation of α2 expression resulted in 
statistically significant attenuation of anoikis 
(Fig. 3). This attenuation was more 
pronounced in MCF-7 cells compared to 
HepG2 cells. It is noteworthy that, prior to 
plating on poly-HEMA, the percentage of 
dead cells was negligible (<5% after 
incubation with siRNA), indicating that 
treatment with siRNAs was not toxic. Thus, 
together with the data on cell stimulation 
with anti-α2 antibodies (Fig. 1), the 
experiments with genetic silencing of α2 
prove that α2β1 integrin can promote anoikis 
at least in two human carcinoma cell lines of 
different tissue origin. 
 
 
 
 
Figure 2: Silencing of  α2 by siRNA. Fifty percent confluent MCF-7 (A, C) or HepG2 
(B, D) cells were treated with 50 nM control (1) or α2-specific (2) siRNAs. (A, B), RT-
PCR. PCR-amplified fragments of β-actin cDNA and α2-cDNA were resolved  in a 
1,5% agarose gel, scanned under UV light followed by densitometry. (C, D), Western 
blottting. Thirty μg of total cellular protein were resolved in SDS-PAGE and blotted 
onto nitrocellulose. Blots were probed with α-tubulin antibody (1:1000) or α2 antibody 
(1:500). The Y axis shows the ratio integrin/β-actin (A, B) or integrin/α-tubulin (C, D) 
in cells treated with respective integrin subunit specific siRNA to that in cells treated 
with control siRNA (100%).  
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The role of integrins in cell survival is 
multifaceted. The bulk of literature provides 
evidence for the anti-apoptotic role of these 
receptors. The antagonists of αvβ3 that block 
its binding to matrix trigger apoptosis of 
angiogenic cells of chicken embryo (Brooks 
et al. 1994), endothelial cells grown in a 3-
dimensional gel (Kuzuya et.al. 1999), brain 
tumor cells (Taga et al. 2002) and melanoma 
(Koistinen et al. 2004). However, much 
fewer data implicate integrins in pro-
apoptotic signaling. We have demonstrated 
that αvβ3 receptor was capable of 
stimulating anoikis in colon carcinoma cells 
(Kozlova et al. 2001). These results were 
independently confirmed in endothelial cells 
and osteoclasts (Cheresh and Stupack 2002; 
Zhao et al. 2005). 
 
 
Figure 3: Effects of Integrin Silencing on Anoikis. Cells were treated with control 
(closed bars) or α2-specific (open bars) siRNAs and labeled with [U-14C]thymidine. 
Further procedures were as in Fig. 1. Apoptosis of  control siRNA treated cells was 
regarded as 100%. Shown are the mean  ± s.e.m. of  three independent experiments 
with four replicates in each. *P < 0.02, #P < 0.05 compared with control. 
 
As for α2β1, its down-regulation induced 
apoptosis of MDCK cells grown in a 3-
dimensional collagen gel (Saelman et.al. 
1995); also, inhibition of α2β1 caused death 
of colon carcinoma cells adhered on collagen 
(Buda et al. 2003). In contrast, this study 
shows the pro-apoptotic role for α2β1 
receptor in cells deprived from matrix. One 
candidate for death signaling downstream of 
α2β1 engagement can be caspase 8 given 
that this enzyme was required for another 
type of cell death, i.e., integrin-mediated 
apoptosis via unligated β1 family integrins 
(Cheresh and Stupack 2002). The `atypical' 
effect of integrins on apoptosis elucidates 
their involvement in versatile and efficient 
pathways of the cell survival control. The 
essence of these pathways is that the same 
receptor sends a `rescue' signal in a normal 
physiological situation and shifts it to a 
`death' signal under abnormal conditions 
when the death of `homeless' cells would be 
advantageous for the population. 
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